Suppr超能文献

氨溴索缓释制剂的生物利用度。第一部分:体外溶出度研究。

Bioavailability of ambroxol sustained release preparations. Part I: In vitro dissolution studies.

作者信息

Alighieri T, Avanessian S, Berlini S, Bianchi S G, Deluigi P, Valducci R, Guelen P J

机构信息

Euderma S.R.L., Rimini, Italy.

出版信息

Arzneimittelforschung. 1988 Jan;38(1):92-4.

PMID:3365281
Abstract

The in vitro dissolution of two ambroxol-HCl containing sustained release preparations (75 mg) and the effect of pH of the dissolution medium on the dissolution rats were investigated. The studies were carried out using the USP XXI paddle method. A new ambroxol HCl sustained release formulation based on a dialyzing membrane for controlled release shows a longer release action as compared to a standard sustained release preparation from commercial source which is based on spheroids constituted by a lipid matrix. The in vitro release rate of the latter product also appears to be more pH dependent.

摘要

研究了两种含盐酸氨溴索的缓释制剂(75毫克)的体外溶出情况以及溶出介质的pH值对溶出速率的影响。采用美国药典 XXI 桨法进行研究。一种基于透析膜的新型盐酸氨溴索控释制剂,与市售基于脂质基质球体的标准缓释制剂相比,显示出更长的释放作用。后一种产品的体外释放速率似乎也更依赖于pH值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验